In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: Bio-Technology General's BioLon

This article was originally published in The Gray Sheet

Executive Summary

Bio-Technology General's BioLon: Firm receives FDA approvable letter Feb. 3 for the 1% sodium hyaluronate viscoelastic lubricant for use in ophthalmic procedures such as cataract removal. The Iselin, New Jersey company says final approval is expected following FDA inspection of the contracted final sterilizer for the product and submission of final labeling...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts